Nanjing IASO Biotherapeutics announced that it has raised funds in a round of funding on January 13, 2023. The transaction included participation from new investors, Shanghai Chuanghehui Investment Management Co., Ltd. and Jointown Pharmaceutical Group Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.21 CNY | 0.00% | -3.86% | +17.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.12% | 4.31B | |
+17.35% | 71.39B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
-3.38% | 3.93B | |
-2.61% | 3.86B | |
+22.08% | 3.64B | |
+7.96% | 3.29B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd